An adverse event was defined as any untoward medical occurrence, irrespective of its suspected relationship to study medications.
An adverse event was defined as any untoward medical occurrence, irrespective of its suspected relationship to the study medications.
AdhereTech began a pilot program with The Walter Reed National Military Medical Center this last year involving patients receiving study medications from the hospital's investigational pharmacy.
The few adverse events recorded were not serious and not related to study medications.
No significant differences in terms of preference scores were found between the two study medications (3.2 ± 1.1 for rizatriptan vs. 2.9 ± 1.3 for frovatriptan).
Tolerability was similar with both study medications; DFN-11 treatment was associated with fewer triptan sensations than the 6-mg dose.
All serous adverse events were judged to be unrelated to study medications.
A nurse administered study medications according to weight-based guidelines for fractions of tablets.
Study medications were administered by the nurses according to modified WHO recommendations for weight-based administration of fractions of tablets.
Study medications were administered with water, and patients were given a glass of milk after each dose of study medication.
Children were not informed of their treatment regimen, but the color and taste of study medications were dissimilar.
